http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3031777-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55ad301cc7a70e081404f170702e471a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-32
filingDate 2019-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77e5dda81d25f23b17b66be35184e995
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d995df33158a614103b6ff4b19ff7efa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c14097d1d272c112f5f891551e448a9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d1aedaaf7e129433c5dfbe5a7935968
publicationDate 2019-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-3031777-A1
titleOfInvention Crystalline form of olaparib
abstract The present invention provides a novel crystalline form of Olaparib comprising Olaparib and benzyl alcohol, compositions thereof, and the use of this crystalline form in the treatment of cancers, such as germline BRCA-mutated (gBRCAm) advanced ovarian cancer.
priorityDate 2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87348083
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448145875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21868444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452241490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23661960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453839387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559052

Total number of triples: 50.